TGF-beta in kidney fibrosis: a target for gene therapy.
Border
W A
WA
Division of Nephrology, University of Utah School of Medicine, Salt Lake City 84132, USA.
Noble
N A
NA
D000818:Animals; D003900:Desoxycorticosterone / Q000235:genetics*; D003928:Diabetic Nephropathies / Q000209:etiology* / Q000628:therapy; D005355:Fibrosis; D015316:Genetic Therapy; D005921:Glomerulonephritis / Q000209:etiology* / Q000628:therapy; D006084:Graft Rejection; D006801:Humans; D007668:Kidney / Q000473:pathology*; D016030:Kidney Transplantation / Q000276:immunology; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000502:physiology*
D016212:Transforming Growth Factor beta; D003900:Desoxycorticosterone